TITLE

P03 The use of BRUM1 resequencing microarray to identify mutations in patients with neonatal cholestasis

AUTHOR(S)
Hartley, J; Bruce, C; Brown, R; McKay, K; Bauman, U; Sturm, E; Udd, B; Mckiernan, P; McMullen, D; Mansson, J; McDonald, F; Maher, E; Knisely, A; Hendriksz, C; Kelly, D; Gissen, P
PUB. DATE
September 2010
SOURCE
Gut;Sep2010 Supp, Vol. 59, pA12
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction Neonatal cholestasis is the presenting clinical feature of serious and potentially life limiting liver diseases such as progressive familial intrahepatic cholestasis (PFIC), arthrogryposis-renal-cholestasis (ARC) syndrome and Niemann Pick C (NPC) disease. A single rapid molecular test to confirm the diagnosis would reduce the delay from molecular genetic investigation at multiple diagnostic centres thus facilitating optimal clinical management and counselling. We have designed a resequencing microarray (BRUM1) capable of simultaneously sequencing multiple genes associated with neonatal cholestasis. Aim To assess the utility of BRUM1 as a first-line molecular investigation for patients with neonatal cholestasis in whom an inherited causes is suspected. Method DNA from 95 infants with neonatal cholestasis in whom an inherited cause was suspected was amplified by PCR and hybridised to BRUM1 (validated against reference sequencing with 98.9% agreement (CI 0.97 to >0.99)) for simultaneous sequencing of the main causes of inherited disease in this group which included ATP8B1, ABCB11, ABCB4, VPS33B, VIPAR, NPC1 and NPC2. Children with known α-1 antitrypsin deficiency or Alagille syndrome were not included. Results 30 infants had pathogenic mutations, which cause neonatal cholestasis. 23 of the mutations were novel. Results In this cohort of patients, 30.5% of infants with neonatal cholestasis had a genetic diagnosis confirmed by BRUM1. The average time to diagnosis was 5–25 days. Conclusion A specific and rapid genetic diagnosis in infants with a phenotype of neonatal cholestasis can be made using a single resequencing microarray, to optimise clinical management and facilitate appropriate counselling of families.
ACCESSION #
66108813

 

Related Articles

  • Diagnosis of alpha-1-antitrypsin deficiency in bleeding disorder-related neonatal death. Kats-Ugurlu, Gursah; Hogeveen, Marije; Driessen, Ann; van den Ouweland, Ans M. W.; Hulsbergen-van de Kaa, Christina // European Journal of Pediatrics. Supplement;2011, Vol. 170, p103 

    Alpha-1-antitrypsin (AAT) deficiency is a rare genetic disorder characterized by hepatitis in neonates, childhood and adulthood (protease inhibitor (PI)*ZZ) and emphysema with or without hepatitis (PI*ZZ)/(PI*SS,SZ or null) in adulthood. We report the case of a female neonate born at 40 weeks of...

  • Diagnosis of alpha-1-antitrypsin deficiency in bleeding disorder-related neonatal death. Kats-Ugurlu, Gursah; Hogeveen, Marije; Driessen, Ann; Van den Ouweland, Ans M. W.; De Kaa, Christina Hulsbergen-van // European Journal of Pediatrics;Jan2011, Vol. 170 Issue 1, p103 

    lpha-1-antitrypsin (AAT) deficiency is a rare genetic disorder characterized by hepatitis in neonates, childhood and adulthood (protease inhibitor (PI)*ZZ) and emphysema with or without hepatitis (PI*ZZ)/(PI*SS,SZ or null) in adulthood. We report the case of a female neonate born at 40 weeks of...

  • Development of a High-Throughput Resequencing Array for the Detection of Pathogenic Mutations in Osteogenesis Imperfecta. Wang, Yao; Cui, Yazhou; Zhou, Xiaoyan; Han, Jinxiang // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Objective: Osteogenesis imperfecta (OI) is a rare inherited skeletal disease, characterized by bone fragility and low bone density. The mutations in this disorder have been widely reported to be on various exonal hotspots of the candidate genes, including COL1A1, COL1A2, CRTAP, LEPRE1, and...

  • DEVELOPMENT OF A RETINITIS PIGMENTOSA (RP) GENOTYPING MICROARRAY AND DETECTION OF KNOWN AND NOVEL MUTATIONS IN A COHORT OF NORTHERN IRISH RP PATIENTS. Clark, G. R.; Muszynska, D.; Alexander, S.; Crowe, P.; O'Neill, J.; McKay, G. J.; Silvestri, G.; Simpson, D. A. C. // Ulster Medical Journal;2009, Vol. 78 Issue 1, p71 

    The inherited retinal disease Retinitis Pigmentosa (RP) is extremely genetically heterogeneous, with 20 genes implicated in non-syndromic recessive RP to date. However, it is very difficult to identify the causative mutation when a new patient presents. Therefore, we have developed an Affymetrix...

  • Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses. Ishiura, Hiroyuki; Takahashi, Yuji; Hayashi, Toshihiro; Saito, Kayoko; Furuya, Hirokazu; Watanabe, Mitsunori; Murata, Miho; Suzuki, Mikiya; Sugiura, Akira; Sawai, Setsu; Shibuya, Kazumoto; Ueda, Naohisa; Ichikawa, Yaeko; Kanazawa, Ichiro; Goto, Jun; Tsuji, Shoji // Journal of Human Genetics;Mar2014, Vol. 59 Issue 3, p163 

    Hereditary spastic paraplegia (HSP) is one of the most genetically heterogeneous neurodegenerative disorders characterized by progressive spasticity and pyramidal weakness of lower limbs. Because >30 causative genes have been identified, screening of multiple genes is required for establishing...

  • Fetal complications of obstetric cholestasis. Reid, Richard; Ivey, K.J.; Rencoret, R.H.; Storey, B. // British Medical Journal;4/10/1976, Vol. 1 Issue 6014, p870 

    Examines the fetal complications of obstetrics cholestasis. Occurrence of intrauterine and neonatal death in patients with obstetrics cholestasis; Treatment for postpartum hemorrhage; Influence of obstetric cholestasis with increased maternal morbidity.

  • Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant. Steinbach, M.; Clark, R. H.; Kelleher, A. S.; Flores, C.; White, R.; Chace, D. H.; Spitzer, A. R. // Journal of Perinatology;Feb2008, Vol. 28 Issue 2, p129 

    Objective:The primary aim of this study was to determine if an association exists between amino-acid levels and development of cholestasis. The secondary aim of our amino-acid dose comparison trial was to identify factors associated with the development of prolonged cholestatic jaundice.Study...

  • Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment. Boga, Salih; Jain, Dhanpat; Schilsky, Michael L. // Pediatric Gastroenterology, Hepatology & Nutrition;Sep2015, Vol. 18 Issue 3, p202 

    Progressive familial intrahepatic cholestasis type 3 (PFIC3) is an autosomal recessive disorder of cholestasis of hepatocellular origin, typically seen in infancy or childhood caused by a defect in the ABCB4 located on chromosome 7. Here we report on an older patient, aged 15, who presented with...

  • A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes. Dufke, Claudia; Schlipf, Nina; Schüle, Rebecca; Bonin, Michael; Auer-Grumbach, Michaela; Stevanin, Giovanni; Depienne, Christel; Kassubek, Jan; Klebe, Stephan; Klimpe, Sven; Klopstock, Thomas; Otto, Susanne; Poths, Sven; Seibel, Andrea; Stolze, Henning; Gal, Andreas; Schöls, Ludger; Bauer, Peter // Neurogenetics;Aug2012, Vol. 13 Issue 3, p215 

    Hereditary spastic paraplegias (HSP) are a heterogeneous group of neurological disorders. Insidiously progressive spastic weakness of the lower extremities is the common criterion in all forms described. Clinically, HSP is differentiated into pure (uncomplicated) and complex (complicated) forms....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics